Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: Application to analysis of murine muscles during cancer cachexia

Maria Lima, Shuichi Sato, Reilly T. Enos, John W. Baynes, James Carson

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cachexia, characterized by skeletal muscle mass loss, is a major contributory factor to patient morbidity and mortality during cancer. However, there are no reports on the rate of myofibrillar protein synthesis (MPS) in skeletal muscles that vary in primary metabolic phenotype during cachexia, in large part because of the small-size muscles and regional differences in larger muscles in the mouse. Here, we describe a sensitive method for measurement of MPS and its application to analysis of MPS in specific muscles of mice with (ApcMin/+) and without (C57BL/6) cancer cachexia. Mice were injected with a loading dose of deuterated phenylalanine (D5F ), and myofibrillar proteins were extracted from skeletal muscles at 30 min. The relative concentrations of D5F and naturally occurring phenylalanine (F) in the myofibrillar proteins and the amino acid pool were quantified by ultra-performance liquid chromatograph (UPLC) mass spectrometry (MS). The rate of MPS was determined from D5F -to-F ratio in the protein fraction compared with the amino acid pool. The rate of MPS, measured in 2-5 mg of muscle protein, was reduced by up to 65% with cachexia in the soleus, plantaris, diaphragm, and oxidative and glycolytic regions of the gastrocnemius. The rate of MPS was significantly higher in the oxidative vs. glycolytic gastrocnemius muscle. A sufficiently sensitive UPLC MS method requiring a very small amount of muscle has been developed to measure the rate of MPS in various mouse muscles. This method should be useful for studies in other animal models for quantifying effects of cancer and anti-cancer therapies on protein synthesis in cachexia, and particularly for analysis of sequential muscle biopsies in a wide range of animal and human studies.

Original languageEnglish (US)
Pages (from-to)824-828
Number of pages5
JournalJournal of applied physiology
Volume114
Issue number6
DOIs
StatePublished - Mar 15 2013

Fingerprint

Muscle Neoplasms
Cachexia
Mass Spectrometry
Proteins
Muscles
Skeletal Muscle
Phenylalanine
Neoplasms
Amino Acids
Muscle Proteins
Diaphragm

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)

Cite this

Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis : Application to analysis of murine muscles during cancer cachexia. / Lima, Maria; Sato, Shuichi; Enos, Reilly T.; Baynes, John W.; Carson, James.

In: Journal of applied physiology, Vol. 114, No. 6, 15.03.2013, p. 824-828.

Research output: Contribution to journalArticle

@article{fd0e33d7216747f693d4d64275bc8326,
title = "Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: Application to analysis of murine muscles during cancer cachexia",
abstract = "Cachexia, characterized by skeletal muscle mass loss, is a major contributory factor to patient morbidity and mortality during cancer. However, there are no reports on the rate of myofibrillar protein synthesis (MPS) in skeletal muscles that vary in primary metabolic phenotype during cachexia, in large part because of the small-size muscles and regional differences in larger muscles in the mouse. Here, we describe a sensitive method for measurement of MPS and its application to analysis of MPS in specific muscles of mice with (ApcMin/+) and without (C57BL/6) cancer cachexia. Mice were injected with a loading dose of deuterated phenylalanine (D5F ), and myofibrillar proteins were extracted from skeletal muscles at 30 min. The relative concentrations of D5F and naturally occurring phenylalanine (F) in the myofibrillar proteins and the amino acid pool were quantified by ultra-performance liquid chromatograph (UPLC) mass spectrometry (MS). The rate of MPS was determined from D5F -to-F ratio in the protein fraction compared with the amino acid pool. The rate of MPS, measured in 2-5 mg of muscle protein, was reduced by up to 65{\%} with cachexia in the soleus, plantaris, diaphragm, and oxidative and glycolytic regions of the gastrocnemius. The rate of MPS was significantly higher in the oxidative vs. glycolytic gastrocnemius muscle. A sufficiently sensitive UPLC MS method requiring a very small amount of muscle has been developed to measure the rate of MPS in various mouse muscles. This method should be useful for studies in other animal models for quantifying effects of cancer and anti-cancer therapies on protein synthesis in cachexia, and particularly for analysis of sequential muscle biopsies in a wide range of animal and human studies.",
author = "Maria Lima and Shuichi Sato and Enos, {Reilly T.} and Baynes, {John W.} and James Carson",
year = "2013",
month = "3",
day = "15",
doi = "10.1152/japplphysiol.01141.2012",
language = "English (US)",
volume = "114",
pages = "824--828",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis

T2 - Application to analysis of murine muscles during cancer cachexia

AU - Lima, Maria

AU - Sato, Shuichi

AU - Enos, Reilly T.

AU - Baynes, John W.

AU - Carson, James

PY - 2013/3/15

Y1 - 2013/3/15

N2 - Cachexia, characterized by skeletal muscle mass loss, is a major contributory factor to patient morbidity and mortality during cancer. However, there are no reports on the rate of myofibrillar protein synthesis (MPS) in skeletal muscles that vary in primary metabolic phenotype during cachexia, in large part because of the small-size muscles and regional differences in larger muscles in the mouse. Here, we describe a sensitive method for measurement of MPS and its application to analysis of MPS in specific muscles of mice with (ApcMin/+) and without (C57BL/6) cancer cachexia. Mice were injected with a loading dose of deuterated phenylalanine (D5F ), and myofibrillar proteins were extracted from skeletal muscles at 30 min. The relative concentrations of D5F and naturally occurring phenylalanine (F) in the myofibrillar proteins and the amino acid pool were quantified by ultra-performance liquid chromatograph (UPLC) mass spectrometry (MS). The rate of MPS was determined from D5F -to-F ratio in the protein fraction compared with the amino acid pool. The rate of MPS, measured in 2-5 mg of muscle protein, was reduced by up to 65% with cachexia in the soleus, plantaris, diaphragm, and oxidative and glycolytic regions of the gastrocnemius. The rate of MPS was significantly higher in the oxidative vs. glycolytic gastrocnemius muscle. A sufficiently sensitive UPLC MS method requiring a very small amount of muscle has been developed to measure the rate of MPS in various mouse muscles. This method should be useful for studies in other animal models for quantifying effects of cancer and anti-cancer therapies on protein synthesis in cachexia, and particularly for analysis of sequential muscle biopsies in a wide range of animal and human studies.

AB - Cachexia, characterized by skeletal muscle mass loss, is a major contributory factor to patient morbidity and mortality during cancer. However, there are no reports on the rate of myofibrillar protein synthesis (MPS) in skeletal muscles that vary in primary metabolic phenotype during cachexia, in large part because of the small-size muscles and regional differences in larger muscles in the mouse. Here, we describe a sensitive method for measurement of MPS and its application to analysis of MPS in specific muscles of mice with (ApcMin/+) and without (C57BL/6) cancer cachexia. Mice were injected with a loading dose of deuterated phenylalanine (D5F ), and myofibrillar proteins were extracted from skeletal muscles at 30 min. The relative concentrations of D5F and naturally occurring phenylalanine (F) in the myofibrillar proteins and the amino acid pool were quantified by ultra-performance liquid chromatograph (UPLC) mass spectrometry (MS). The rate of MPS was determined from D5F -to-F ratio in the protein fraction compared with the amino acid pool. The rate of MPS, measured in 2-5 mg of muscle protein, was reduced by up to 65% with cachexia in the soleus, plantaris, diaphragm, and oxidative and glycolytic regions of the gastrocnemius. The rate of MPS was significantly higher in the oxidative vs. glycolytic gastrocnemius muscle. A sufficiently sensitive UPLC MS method requiring a very small amount of muscle has been developed to measure the rate of MPS in various mouse muscles. This method should be useful for studies in other animal models for quantifying effects of cancer and anti-cancer therapies on protein synthesis in cachexia, and particularly for analysis of sequential muscle biopsies in a wide range of animal and human studies.

UR - http://www.scopus.com/inward/record.url?scp=84876572482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876572482&partnerID=8YFLogxK

U2 - 10.1152/japplphysiol.01141.2012

DO - 10.1152/japplphysiol.01141.2012

M3 - Article

C2 - 23329823

AN - SCOPUS:84876572482

VL - 114

SP - 824

EP - 828

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 6

ER -